| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.08▲ | 5.06▲ | 5.06▲ | 5.15▼ | 5.77▼ |
| MA10 | 5.07▲ | 5.07▲ | 5.08▲ | 5.06▲ | 7.39▼ |
| MA20 | 5.06▲ | 5.08▲ | 5.11▼ | 5.54▼ | 10.68▼ |
| MA50 | 5.06▲ | 5.17▼ | 5.17▼ | 7.64▼ | 15.08▼ |
| MA100 | 5.07▲ | 5.13▼ | 4.96▲ | 10.92▼ | 25.40▼ |
| MA200 | 5.10▼ | 5.07▲ | 6.11▼ | 13.84▼ | 37.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.005▲ | -0.004▼ | 0.161▲ | -0.433▼ |
| RSI | 56.158▲ | 48.586▼ | 46.939▼ | 31.714▼ | 26.597▼ |
| STOCH | 61.399 | 42.982 | 52.751 | 69.954 | 8.258▼ |
| WILL %R | -14.286▲ | -34.211 | -43.182 | -37.164 | -92.976▼ |
| CCI | 42.695 | 27.053 | 2.011 | 33.953 | -101.917▼ |
|
Sunday, June 15, 2025 09:05 PM
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease ...
|
|
Friday, May 30, 2025 07:22 AM
Piper Sandler lowered the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) to $81 from $110 while keeping an Overweight rating on the shares. The price target decrease followed the ...
|
|
Friday, May 30, 2025 07:21 AM
Chardan slashed the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) on May 27, lowering it to $18 from $40 while maintaining a Buy rating on the shares. Although the firm is bullish on ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 4.99 | 5.15 | 4.95 | 5.08 | 806,358 |
| 12/06/25 | 5.05 | 5.18 | 5.01 | 5.07 | 652,183 |
| 11/06/25 | 5.28 | 5.39 | 5.09 | 5.10 | 843,290 |
| 10/06/25 | 5.28 | 5.45 | 5.23 | 5.255 | 597,505 |
| 09/06/25 | 5.49 | 5.5295 | 5.045 | 5.25 | 2,323,216 |
| 06/06/25 | 5.11 | 5.44 | 5.05 | 5.41 | 1,250,560 |
| 05/06/25 | 4.87 | 5.20 | 4.76 | 5.06 | 1,496,886 |
| 04/06/25 | 4.83 | 4.88 | 4.66 | 4.88 | 1,142,961 |
| 03/06/25 | 4.66 | 4.85 | 4.53 | 4.83 | 1,307,546 |
| 02/06/25 | 4.56 | 4.81 | 4.53 | 4.66 | 1,775,839 |
|
|
||||
|
|
||||
|
|